The Food and Drug Administration has granted Fast Track designation to PMN310 for the treatment of Alzheimer disease.

Neuroanatomical variability is associated with early substance use initiation, according to a cohort study published in JAMA Network Open.

Screening for emotional and cognitive issues after ischemic stroke does not improve societal participation at 1 year.

The structured intervention benefit was consistent for APOE ε4 carriers and noncarriers but seemed greater for adults with lower vs higher baseline cognition.

Topline data were announced from a phase 3 trial evaluating gefurulimab in adults with anti-acetylcholine receptor antibody-positive generalised myasthenia gravis.

Only 36.8 percent of adolescents diagnosed with cannabis use disorder (CUD) complete treatment, according to a study published online July 22 in Pediatric Repor ...

Treatment of TBI with magnesium-ibogaine reduces spatiotemporal complexity of brain activity and slows cortical oscillations in the brain at rest.

Migraine is associated with a significantly increased risk for all-cause dementia, Alzheimer disease (AD), and vascular dementia (VaD), particularly among women and patients who have migraine with ...

HealthDay News — Health care provider stigma toward substance use disorder (SUD) varies by condition and provider, according to a study published online July 23 in Addiction.

Dementia with Lewy bodies (DLB), the second most common type of dementia, requires a multifactorial approach to reduce symptoms.

Remote-scalable CBT-based chronic pain treatments yield modest improvements in high-impact chronic pain compared with usual care.

Living near green spaces before and during pregnancy, as well as in early childhood, may lower the risk for neurodevelopmental disorders.